 | • レポートコード：QYR9NV17617 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、胞巣状横紋筋肉腫治療の世界市場について調査・分析し、胞巣状横紋筋肉腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（外科手術、化学療法、放射線療法）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胞巣状横紋筋肉腫治療市場動向 ・主要企業別マーケットシェア ・胞巣状横紋筋肉腫治療の種類別市場規模2014-2019 （外科手術、化学療法、放射線療法） ・胞巣状横紋筋肉腫治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・胞巣状横紋筋肉腫治療の北米市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療の中国市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療の日本国内市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療のインド市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly、GlaxoSmithKline、Boehringer Ingelheim、Bristol-Myers Squibb、Roche、Oasmia、Celgene、Pfizer、Johnson & Johnson） ・胞巣状横紋筋肉腫治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Alveolar rhabdomyosarcoma (ARMS) is a type of soft tissue sarcoma that originates from the connective tissues of the body such as bone, muscle, cartilage, and ligaments.In 2018, the global Alveolar Rhabdomyosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Alveolar Rhabdomyosarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alveolar Rhabdomyosarcoma Treatment development in North America, Europe and Asia-Pacific.
The key players covered in this study
Eli Lilly
GlaxoSmithKline
Boehringer Ingelheim
Bristol-Myers Squibb
Roche
Oasmia
Celgene
Pfizer
Johnson & Johnson
Market segment by Type, the product can be split into
Surgical Operation
Chemotherapy
Radiotherapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific
The study objectives of this report are:
To analyze global Alveolar Rhabdomyosarcoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Alveolar Rhabdomyosarcoma Treatment development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Alveolar Rhabdomyosarcoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alveolar Rhabdomyosarcoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgical Operation
1.4.3 Chemotherapy
1.4.4 Radiotherapy
1.5 Market by Application
1.5.1 Global Alveolar Rhabdomyosarcoma Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Alveolar Rhabdomyosarcoma Treatment Market Size
2.2 Alveolar Rhabdomyosarcoma Treatment Growth Trends by Regions
2.2.1 Alveolar Rhabdomyosarcoma Treatment Market Size by Regions (2019-2025)
2.2.2 Alveolar Rhabdomyosarcoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Alveolar Rhabdomyosarcoma Treatment Market Size by by Players
3.1.1 Global Alveolar Rhabdomyosarcoma Treatment Revenue by by Players (2014-2019)
3.1.2 Global Alveolar Rhabdomyosarcoma Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Alveolar Rhabdomyosarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Alveolar Rhabdomyosarcoma Treatment Key Players Head office and Area Served
3.3 Key Players Alveolar Rhabdomyosarcoma Treatment Product/Solution/Service
3.4 Date of Enter into Alveolar Rhabdomyosarcoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Alveolar Rhabdomyosarcoma Treatment Market Size by Type (2014-2019)
4.2 Global Alveolar Rhabdomyosarcoma Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Alveolar Rhabdomyosarcoma Treatment Market Size (2014-2019)
5.2 Alveolar Rhabdomyosarcoma Treatment Key Players in North America
5.3 North America Alveolar Rhabdomyosarcoma Treatment Market Size by Type
5.4 North America Alveolar Rhabdomyosarcoma Treatment Market Size by Application
6 Europe
6.1 Europe Alveolar Rhabdomyosarcoma Treatment Market Size (2014-2019)
6.2 Alveolar Rhabdomyosarcoma Treatment Key Players in Europe
6.3 Europe Alveolar Rhabdomyosarcoma Treatment Market Size by Type
6.4 Europe Alveolar Rhabdomyosarcoma Treatment Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size (2014-2019)
7.2 Alveolar Rhabdomyosarcoma Treatment Key Players in Asia-Pacific
7.3 Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size by Type
7.4 Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size by Application
8 International Players Profiles
8.1 Eli Lilly
8.1.1 Eli Lilly Company Details
8.1.2 Company Description and Business Overview
8.1.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.1.4 Eli Lilly Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019))
8.1.5 Eli Lilly Recent Development
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Company Details
8.2.2 Company Description and Business Overview
8.2.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.2.4 GlaxoSmithKline Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.2.5 GlaxoSmithKline Recent Development
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Company Details
8.3.2 Company Description and Business Overview
8.3.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.3.4 Boehringer Ingelheim Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.3.5 Boehringer Ingelheim Recent Development
8.4 Bristol-Myers Squibb
8.4.1 Bristol-Myers Squibb Company Details
8.4.2 Company Description and Business Overview
8.4.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.4.4 Bristol-Myers Squibb Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.4.5 Bristol-Myers Squibb Recent Development
8.5 Roche
8.5.1 Roche Company Details
8.5.2 Company Description and Business Overview
8.5.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.5.4 Roche Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.5.5 Roche Recent Development
8.6 Oasmia
8.6.1 Oasmia Company Details
8.6.2 Company Description and Business Overview
8.6.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.6.4 Oasmia Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.6.5 Oasmia Recent Development
8.7 Celgene
8.7.1 Celgene Company Details
8.7.2 Company Description and Business Overview
8.7.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.7.4 Celgene Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.7.5 Celgene Recent Development
8.8 Pfizer
8.8.1 Pfizer Company Details
8.8.2 Company Description and Business Overview
8.8.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.8.4 Pfizer Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.8.5 Pfizer Recent Development
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Company Details
8.9.2 Company Description and Business Overview
8.9.3 Alveolar Rhabdomyosarcoma Treatment Introduction
8.9.4 Johnson & Johnson Revenue in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
8.9.5 Johnson & Johnson Recent Development
9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details
Table Alveolar Rhabdomyosarcoma Treatment Key Market Segments
Table Key Players Alveolar Rhabdomyosarcoma Treatment Covered
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Surgical Operation Figures
Table Key Players of Surgical Operation
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Radiotherapy Figures
Table Key Players of Radiotherapy
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Alveolar Rhabdomyosarcoma Treatment Report Years Considered
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Share by Regions 2014-2019
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Share by Regions 2014-2019
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Alveolar Rhabdomyosarcoma Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Share by by Players (2014-2019)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Share by by Players in 2018
Table Global Alveolar Rhabdomyosarcoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alveolar Rhabdomyosarcoma Treatment Product/Solution/Service
Table Date of Enter into Alveolar Rhabdomyosarcoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size Share by Type (2014-2019)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size Share by Application (2014-2019)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Alveolar Rhabdomyosarcoma Treatment Revenue Market Share by Application in 2018
Figure North America Alveolar Rhabdomyosarcoma Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Alveolar Rhabdomyosarcoma Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Alveolar Rhabdomyosarcoma Treatment Market Share (2018-2019)
Table North America Alveolar Rhabdomyosarcoma Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Alveolar Rhabdomyosarcoma Treatment Market Share by Type 2014-2019
Table North America Alveolar Rhabdomyosarcoma Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Alveolar Rhabdomyosarcoma Treatment Market Share by Application 2014-2019
Figure Europe Alveolar Rhabdomyosarcoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Alveolar Rhabdomyosarcoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Alveolar Rhabdomyosarcoma Treatment Market Share (2018-2019)
Table Europe Alveolar Rhabdomyosarcoma Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Alveolar Rhabdomyosarcoma Treatment Market Share by Type 2014-2019
Table Europe Alveolar Rhabdomyosarcoma Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Alveolar Rhabdomyosarcoma Treatment Market Share by Application 2014-2019
Figure Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Alveolar Rhabdomyosarcoma Treatment Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Alveolar Rhabdomyosarcoma Treatment Market Share (2018-2019)
Table Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Share by Type 2014-2019
Table Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Share by Application 2014-2019
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Eli Lilly Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Roche Company Details
Table Roche Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Roche Recent Development
Table Oasmia Company Details
Table Oasmia Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Oasmia Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Oasmia Recent Development
Table Celgene Company Details
Table Celgene Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Celgene Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Celgene Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Alveolar Rhabdomyosarcoma Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Alveolar Rhabdomyosarcoma Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size Share by Regions in 2025
Figure North America Alveolar Rhabdomyosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alveolar Rhabdomyosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Alveolar Rhabdomyosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size by Product (2019-2025)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size by Product in 2025
Table Global Alveolar Rhabdomyosarcoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size by Application (2019-2025)
Figure Global Alveolar Rhabdomyosarcoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
胞巣状横紋筋肉腫治療のグローバル市場：規模・現状・予測2019-2025 Alveolar rhabdomyosarcoma (ARMS) is a type of soft tissue sarcoma that originates from the connective tissues of the body such as bone, muscle, cartilage, and ligaments.In 2018, the global Alveolar Rhabdomyosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ b…- 線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025 Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach …
- 線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025 Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach …
- 横紋筋肉腫薬のグローバル市場調査 2019年 The global Rhabdomyosarcoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhabdomyosarcoma Drug volume and value at global level, regional level and company level. From a global perspective, …
- 横紋筋肉腫薬のグローバル市場調査 2019年 The global Rhabdomyosarcoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhabdomyosarcoma Drug volume and value at global level, regional level and company level. From a global perspective, …